She is formally trained as a molecular biologist (Ph.D. in Molecular Biology, Princeton University) and cancer epidemiologist (M.S. in Epidemiology, University of California, Los Angeles and Master of Public Affairs and Politics, Rutgers University). Dr. Tarleton’s research focuses on comorbidity among cancer survivors.